American Journal of Epidemiology Vol. 102, No. 4: 331-340
Copyright © 1975 by The Johns Hopkins University School of Hygiene and Public Health
other |
SEROEPIDEMIOLOGY OF HUMAN PAPOVAVIRUSES
DISCOVERY OF VIRGIN POPULATIONS AND SOME UNUSUAL PATTERNS OF ANTIBODY PREVALENCE AMONG REMOTE PEOPLES OF THE WORLD1
Brown, P. (National Institute of Neurological Diseases and Stroke, NIH, Bethesda, MD 20014), T. Tsai and D. C. Gajdusek. Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. Am J Epidemiol 102:331–340, 1975.
A total of 1544 sera from 28 diverse and mainly isolated populations were examined forHI antibody to BK virus. A few extremely isolated populations were found with negligibleor absent exposure to the virus, but in most populations, remote or cosmopolitan, antibody appeared in increasing prevalence during early childhood and remained stable throughout adult life. Antibody acquisition and prevalence rates in individual families reflected that of the general population. Examined for HI antibody to JC virus were 393 sera from 9of the 28 populations. Age acquisition and prevalence rates of antibody were similar to those of BK virus, but experience with the 2 viruses was found to occur independently in several population groups, i.e., high exposure to BK with low exposure to JC, or vice-versa. Examined for neutralizing antibody to SV40 were 151 sera with and without BK HI antibody in individuals from several primitive populations. SV40 antibody, mainly in low titer, occurred in 35% of the BK-positive group, but only 5% of the BK-negative group, suggesting that infection with BK or a closely related virus is responsible for antibody directed against SV40 in most humans unexposed to known vaccine or monkey sources of SV40 infection.
antibodies; leukoencephalopathy; progressive multifocal; papovavirus; seroepidemiology; simian virus 40
1From the National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD 20014.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J R Berger Natalizumab and progressive multifocal leucoencephalopathy Ann Rheum Dis, November 1, 2006; 65(suppl_3): iii48 - iii53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Low, B. Magnuson, B. Tsai, and M. J. Imperiale Identification of Gangliosides GD1b and GT1b as Receptors for BK Virus J. Virol., February 1, 2006; 80(3): 1361 - 1366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Engels, R. P. Viscidi, D. A. Galloway, J. J. Carter, J. R. Cerhan, S. Davis, W. Cozen, R. K. Severson, S. de Sanjose, J. S. Colt, et al. Case-Control Study of Simian Virus 40 and Non-Hodgkin Lymphoma in the United States J Natl Cancer Inst, September 15, 2004; 96(18): 1368 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Engels, J. Chen, R. P. Viscidi, K. V. Shah, R. W. Daniel, N. Chatterjee, and M. A. Klebanoff Poliovirus Vaccination during Pregnancy, Maternal Seroconversion to Simian Virus 40, and Risk of Childhood Cancer Am. J. Epidemiol., August 15, 2004; 160(4): 306 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Carter, M. M. Madeleine, G. C. Wipf, R. L. Garcea, P. A. Pipkin, P. D. Minor, and D. A. Galloway Lack of Serologic Evidence for Prevalent Simian Virus 40 Infection in Humans J Natl Cancer Inst, October 15, 2003; 95(20): 1522 - 1530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Viscidi, D. E. M. Rollison, E. Viscidi, B. Clayman, E. Rubalcaba, R. Daniel, E. O. Major, and K. V. Shah Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme Immunoassays Clin. Vaccine Immunol., March 1, 2003; 10(2): 278 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Blaho and S. A. Aaronson Convicting a human tumor virus: Guilt by association? PNAS, July 6, 1999; 96(14): 7619 - 7621. [Full Text] [PDF]
|
|
|
|
|
|
L. Laghi, A. E. Randolph, D. P. Chauhan, G. Marra, E. O. Major, J. V. Neel, and C. R. Boland JC virus DNA is present in the mucosa of the human colon and in colorectal cancers PNAS, June 22, 1999; 96(13): 7484 - 7489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Butel and J. A. Lednicky Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease J Natl Cancer Inst, January 20, 1999; 91(2): 119a - 134a. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. O. Major and J. V. Neel The JC and BK human polyoma viruses appear to be recent introductions to some South American Indian tribes: There is no serological evidence of cross-reactivity with the simian polyoma virus SV40 PNAS, December 22, 1998; 95(26): 15525 - 15530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Rosenthal, M Kress, P Gruss, and G Khoury BK viral enhancer element and a human cellular homolog Science, November 18, 1983; 222(4625): 749 - 755. [Abstract] [PDF]
|
|
|
|
 |
|
 T. F. HOGAN, E. C. BORDEN, J. A. McBAIN, B. L. PADGETT, and D. L. WALKER Human Polyomavirus Infections with JC Virus and BK Virus in Renal Transplant Patients Ann Intern Med, March 1, 1980; 92(3): 373 - 378. [Abstract] [PDF]
|
|